NYU Langone Health’s Department of Psychiatry plans to establish a Center for Psychedelic Medicine, a hallucinatory hub that will support research on treating addiction, chronic pain, opioid addiction and “existential distress” — among other physical and emotional maladies — using psychedelics. NYU researchers are already involved in studies on the treatment of alcoholism, anxiety and major depressive disorder with psilocybin (the active ingredient in magic mushrooms) and the treatment of severe PTSD with MDMA (also known as ecstasy and molly).
The program, announced Wednesday, will also be the home base for NYU’s new Psychedelic Medicine Research Training Program, which will attempt to make psychedelic medicine more mainstream and increase the number of experts in the field.
The new facility is backed by $10 million from donors, including Dr. Bronner’s soaps and psychedelic medicine company MindMed.
Read more at NY Post.
{Matzav.com}
Its 2021. The drug-crop world wants it. The world bends or improves. There are journals on psychedelic studies that one can read.
Best said, this mile I think we travel involves unhealthy people who are selectively their own mess. Maybe it can add to hardships of very disfigured souls who have so long a bad alternative. Best thought is to wonder the future. Maybe the long-term effects are less the world it worries but one says that is a major point. Do not think we want a brain that can not do.
Before you think you want this I say you should watch what you are eating and make vast changes. The very unhealhy pour through bags of potato chips and dying choices about colas even the ones with no sugar. It becomes more than a bagel bag and harder than a fat chicken in paradise.
I hope there is relief for illness.
Does the garter snake have a bow tie?
Organized plan. We will see a change.
How is this center different than the clinics currently available for kicking a drug habit. This center should warn about legalizing pot as addiction doesn’t stop with pot.